← Back to Search

Mobile Health Strategy for Premature Birth

N/A

Waitlist Available

Led By Jason Wang, MD, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women 16-50 years of age

Women who can read, write and understand English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-months

Awards & highlights

Study Summary

This trial will compare a mobile health strategy to a traditional paper-based health strategy to see if it can reduce the number of spontaneous preterm births.

Who is the study for?

This trial is for women aged 16-50 who have had a preterm infant and own a mobile phone. They must be able to read and understand English, with their child previously in neonatal care due to premature birth. Women without prior preterm births or those without a mobile phone are excluded.Check my eligibility

What is being tested?

The study tests the PretermConnect App's effectiveness in reducing recurrent preterm births by enhancing patient engagement, care coordination, and adherence to recommended practices compared to traditional paper-based methods.See study design

What are the potential side effects?

Since this trial involves the use of an app rather than medication, there are no direct medical side effects. However, participants may experience increased screen time which could affect sleep patterns or eye strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman aged between 16 and 50.

Select...

I can read, write, and understand English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Interpregnancy interval

Secondary outcome measures

Breastmilk feeding

Mother-infant bonding

Postpartum depression

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PretermConnect AppExperimental Treatment1 Intervention

Participants will receive health education via a mobile app, PretermConnect

Group II: ControlActive Control1 Intervention

Participants will receive paper-based health education as part of standard of care

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,387 Previous Clinical Trials

17,333,794 Total Patients Enrolled

11 Trials studying Premature Birth

2,879 Patients Enrolled for Premature Birth

University of Pittsburgh Medical CenterOTHER

70 Previous Clinical Trials

75,994 Total Patients Enrolled

Children's Hospital of PhiladelphiaOTHER

708 Previous Clinical Trials

8,581,047 Total Patients Enrolled

12 Trials studying Premature Birth

3,943 Patients Enrolled for Premature Birth

Media Library

Use of PretermConnect App Clinical Trial Eligibility Overview. Trial Name: NCT04663607 — N/A

Premature Birth Research Study Groups: Control, PretermConnect App

Premature Birth Clinical Trial 2023: Use of PretermConnect App Highlights & Side Effects. Trial Name: NCT04663607 — N/A

Use of PretermConnect App 2023 Treatment Timeline for Medical Study. Trial Name: NCT04663607 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open recruitment opportunities for this clinical trial?

"The clinicaltrials.gov website illustrates that this medical trial is no longer actively recruiting subjects. It was initially listed on October 7th 2021, with the last update being made on November 17th 2022. However, there are 262 other research studies seeking out participants at present."

Answered by AI

Do I meet the criteria to be included in this research endeavor?

"This medical experiment is open to 256 individuals aged 16-50 who have given birth prematurely, and meet the following requirements: their infant must be in neonatal intensive care; they must own a device which can download apps from either Apple App Store or Google Play; participants need to provide consent for the trial; some sites may also require extra criteria."

Answered by AI

Does this experiment incorporate elderly individuals?

"The parameters for patient enrollment in this clinical trial are between 16 and 50 years old. For those younger than 16, there are 185 studies available to them; 74 studies can be found for seniors past the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mobile Strategy to Reduce the Risk of Recurrent Preterm Birth

Jason Wang 2021. "Mobile Strategy to Reduce the Risk of Recurrent Preterm Birth". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04663607.